AI Article Synopsis
- The study aimed to assess the incidence of venous thromboembolism (VTE) among transgender women undergoing feminizing cross-sex hormone therapy (CSHT) in the U.S., where different hormone combinations are used compared to Europe.
- The research involved a retrospective chart review of 676 transgender women receiving oral estradiol over a period from 2008 to 2016, totaling 1,286 years of hormone treatment.
- The findings indicated a very low incidence of VTE, with only one case reported, resulting in an incidence rate of 7.8 events per 10,000 person-years.
Article Abstract
Introduction: One of the most serious known adverse effects of feminizing cross-sex hormone therapy (CSHT) is venous thromboembolism (VTE); however, no study has assessed the incidence of VTE from the hormone therapies used in the United States because previous publications on this topic have originated in Europe. CSHT in the United States typically includes estradiol with the antiandrogen spironolactone, whereas in Europe estradiol is prescribed with the progestin cyproterone acetate.
Aim: To estimate the incidence of VTE from the standard feminizing CSHTs used in the United States.
Methods: A retrospective chart review of transgender women who had been prescribed oral estradiol at a District of Columbia community health center was performed.
Main Outcome Measure: The primary outcomes of interest were deep vein thrombosis or pulmonary emboli.
Results: From January 1, 2008 through March 31, 2016, 676 transgender women received oral estradiol-based CSHT for a total of 1,286 years of hormone treatment and a mean of 1.9 years of CSHT per patient. Only one individual, or 0.15% of the population, sustained a VTE, for an incidence of 7.8 events per 10,000 person-years.
Conclusion: There was a low incidence of VTE in this population of transgender women receiving oral estradiol.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jsxm.2016.09.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Validating a Case Definition for Transgender Adults Using Administrative Data.
JAMA Netw Open
January 2025
Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Importance: Administrative health data serve as promising data sources to study transgender health at a population level in the absence of self-reported gender identity.
Objective: To develop and validate case definitions identifying transgender adults in administrative data compared with the reference standard of self-reported gender identity in a universal health care setting.
Design, Setting, And Participants: In this cohort study conducted in Alberta, Canada, data from provincial administrative health data sources including inpatient hospitalizations, emergency department encounters, primary care visits, prescription drug dispensations, and the provincial health insurance registry were linked and used to develop 15 case definitions (9 for transgender women and 6 for transgender men).
Cross-Sectional Evaluation of State-Level Protections, Medical Debt, and Deferred Care Among Sexual and Gender Minority People.
J Gen Intern Med
January 2025
Section of General Internal Medicine, Boston University School of Medicine, Boston, MA, USA.
Background: Millions of Americans have medical debt and/or defer care due to cost. Few studies have examined the association of such health-related financial problems with sexual orientation or gender identity, and whether state-level policies protecting sexual and gender minority (SGM) people affect disparities in such problems.
Objective: To examine the relationships between SGM status, state-level SGM protections, and health-related financial problems.
Influence of androgen receptor on bone health in transgender adults: insights from the COMET study.
J Endocrinol Invest
January 2025
Regional Reference Center for Gender Incongruence (CRRIG) of the Veneto Region, University Hospital of Padova, Padua, Italy.
Purpose: Previous studies show that transgender and gender-diverse (TGD) individuals, especially those assigned male at birth (AMAB), often have low bone mineral density (BMD) before beginning gender-affirming hormone therapy (GAHT). The reasons for this are not fully understood, and the potential role of androgen receptor (AR) polymorphisms - known to affect bone density in the general population - has not been explored. This study aims to assess the impact of AR polymorphisms on bone health in the TGD population.
View Article and Find Full Text PDFAn Intersectional Analysis of Behavioral Financial Hardship and Healthcare Utilization among LGBTQ+ Cancer Survivors.
J Natl Cancer Inst
January 2025
Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Background: lesbian, gay, bisexual, transgender, queer, or another non-heterosexual or cisgender identity (LGBTQ+) cancer survivors experience high financial hardship. However, structural drivers of inequities do not impact all LGBTQ+ individuals equally. Using All of Us data, we conducted an intersectional analysis of behavioral financial hardship among LGBTQ+ cancer survivors.
View Article and Find Full Text PDFThe Digital Transformation and the Right to Health of Young Adults in Bangladesh and Colombia: A Community-Engaged Study.
Health Hum Rights
December 2024
In her 2023 report to the United Nations Human Rights Council on digital innovation, technology, and the right to health, the Special Rapporteur on the right to health underscored the positive impact of the digital transformation on young people, but also noted serious concerns, calling for greater efforts to consult and engage with youth and civil society. In our study, early-career researchers from Bangladesh and Colombia collaborated within a broader international research and advocacy project to investigate how diverse young adults experience digital health and to invite their recommendations and collaborative advocacy. Researchers held focus group discussions and interviews with young adults aged 18-30 (in Bangladesh, predominantly men; in Colombia, people living with HIV, gay men, and transgender women).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!